Lisdexamfetamine Dimesylate: A New Therapeutic Option for Attention-Deficit Hyperactivity Disorder

ISSN： 1172-7047

Source： CNS Drugs, Vol.26, Iss.8, 2012-08, pp. : 691-705

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lisdexamfetamine Dimesylate: In Attention-Deficit Hyperactivity Disorder in Adults

By Weber Juliane Siddiqui M. Asif A.

CNS Drugs, Vol. 23, Iss. 5, 2009-05 ,pp. : 419-425

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine dimesylate: a guide to its use in attention-deficit hyperactivity disorder

Drugs & Therapy Perspectives, Vol. 26, Iss. 10, 2010-10 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

An update on lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder

By Wigal Sharon B Raja Pooja Shukla Ankita

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 137-145

Informa Healthcare

Access to resources Recommend Favorite

New Formulations of Stimulants for Attention-Deficit Hyperactivity Disorder: Therapeutic Potential

By Daniel F. Connor Ronald J. Steingard

CNS Drugs, Vol. 18, Iss. 14, 2004-01 ,pp. : 1011-1030

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine is a promising treatment for children with attention-deficit hyperactivity disorder

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite